Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Cited by (1,000)

Items 601–700 of 1,000

1. Triple Therapy, Dual Therapy, and Modulation of Anticoagulation Intensity
   Davide Capodanno · 2021 · JACC: Cardiovascular Interventions
2. [ESC guidelines 2020: acute coronary syndrome without persistent ST-segment elevation : What is new?]
   Hölger Thiele, Alexander Jobs · 2021 · PubMed
3. Contemporary Use and Clinical Significance of Initial Triple Versus Double Therapy After Percutaneous Coronary Intervention for Myocardial Infarction in Patients With Atrial Fibrillation
   Dae Yong Park, Bianca McLean, Zafer Akman, Darrick K. Li, Golsa Babapour, Michael G. Nanna · 2025 · Journal of the American Heart Association
4. Efficacy and safety of Shuxuening injection in patients with unstable angina: a multicenter, randomized, placebo-controlled trial
   Lintong Yu, Shiyi Tao, Qian Lin, Sheng Gao, Xitian Hu, Xiaoping Li, Xiaofeng Wang, Huijun Chen, Xianyou Ji, Qiufang Lian et al. · 2025 · Phytomedicine
5. Medical Management of Coronary Artery Disease: An Update
   Darshan Hullon, Mohammad Bilal, Nicolas W. Shammas · 2025 · International Journal of Angiology
6. Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease
   Junichi Yamaguchi, Hiroyuki Arashi, Nobuhisa Hagiwara, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi et al. · 2025 · JAMA Cardiology
7. Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How
   Luca Martini, Matteo Lisi, Graziella Pompei, Manfredi Arioti, Francesco Bendandi, Michael Y. Henein, Matteo Cameli, Andrea Rubboli · 2025 · Journal of Clinical Medicine
8. Development of an interpretable machine learning model to predict short-term bleeding risk in patients receiving dual antithrombotic therapy following cardiac surgery
   Haolong Han, Jifan Zhang, Xia Wang, Weihong Ge, Jason Zhensheng Qu · 2025 · International Journal of Clinical Pharmacy
9. Post-Ablation Stroke Despite NOAC Use: Successful Reperfusion Therapy After Dabigatran Reversal with Incidental Discovery of a Large MCA Aneurysm—A Case Report
   Santi Mitra Sari, Wei‐Tso Chen, Chien-Hui Lee, Nai-Hsin Huang, Phyo-Wai Thu, Ling-Lun Teoh, Yumei Wu, An‐Bang Liu · 2025 · Neurology International
10. Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies
    Pierre François Sabouret, Domenico Mario Giamundo, Francesco Costa, Piera Capranzano, Luigi Spadafora, Stefano Cacciatore, Nelsa González Aguado, Marco Bernardi, Ahmed Ibrahim, Ali Abdelaziz et al. · 2026 · Journal of Clinical Medicine
11. Antithrombotic Strategies in Advanced Chronic Kidney Disease: Real-World Comparison of Oral Anticoagulation Alone vs Dual Antithrombotic Therapy
    C C K Chih-Chin Kao, Hui-An Lin, Chien-Yi Hsu, Sheng‐Feng Lin · 2026 · Mayo Clinic Proceedings
12. Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes – A systematic review
    Akash Batta, Razieh Parizad, Juniali Hatwal, Deven Mittal, Manjeet Kumar Goyal, Bishav Mohan · 2026 · Indian Heart Journal
13. Frailty and Coronary Artery Disease: Proposed Pathophysiology and A Complex Interaction Influencing Management and Outcomes in Older Adults
    Ammar Albayati, Lloyd E. Butel-Simoes, Payal Gadre, Georgette Goode, Nicholas John Collins, Aaron Leonid Sverdlov, Andrew Boyle, Mohammed S. Al-Omary · 2026 · Heart Lung and Circulation
14. The year in cardiology: arrhythmias and pacing
    A. John Camm, Gregory Y.H. Lip, RICHARD JOHN SCHILLING, Hugh G Calkins, Jan Steffel · 2020 · European Heart Journal
15. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice
    Matthew William Sherwood, Jonathan Paul Piccini, DaJuanicia N. Holmes, Karen S. Pieper, Benjamin Adam Steinberg, Gregg C. Fonarow, Larry A. Allen, Gerald V. Naccarelli, Peter Russell Kowey, Bernard John Gersh et al. · 2020 · Circulation Cardiovascular Interventions
16. Feasibility of concomitant left atrial appendage closure and percutaneous coronary intervention in patients with acute coronary syndrome and atrial fibrillation: a randomized pilot study
    Denis Losik, Alexander Romanov, Igor O. Grazhdankin, В. В. Шабанов, Dmitry Ponomarev, I. Mikheenko, Ivan S Peregudov, Aleksey G. Filippenko, Н В Бондарь, Lucas V.A. Boersma et al. · 2023 · Heart and Vessels
17. Preventing Lower Limb Graft Thrombosis after Infrainguinal Arterial Bypass Surgery with Antithrombotic Agents (PATENT Study): An International Expert Based Delphi Consensus
    Lorenz Meuli, Thomas H.W. Stadlbauer, Barbara Elisabeth Stähli, Christine Espinola–Klein, Alexander Zimmermann, on behalf of the PATENT Study Collaborators · 2023 · Journal of Clinical Medicine
18. Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial
    Martin Borlich, Uwe Zeymer, Harm Wienbergen, Hans‐Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf et al. · 2023 · Cardiology and Therapy
19. Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design
    Andrea Teira Calderón, Mauro Chiarito, Ignacio Jesus Amat-Santos, Davide Cao, Beatriz Vaquerizo, Alfonso Jurado Román, Paloma Pulido Garrido, Francesco Tartaglia, Héctor M. García‐García, José Luis Díez Gil et al. · 2024 · Cardiovascular revascularization medicine
20. Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
    Diona Gjermeni, Viktoria Anfang, H Vetter, Sofia Szabó, David Hesselbarth, Nadine Gauchel, Patrick Malcolm Siegel, Klaus Kaier, Alexander Kille, Kilian Franke et al. · 2024 · Journal of Thrombosis and Thrombolysis
21. Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
    Rishi Chandiramani, Adhya Mehta, Roger Scott Blumenthal, Marlene S. Williams · 2024 · Current Atherosclerosis Reports
22. Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel
    Mark Anthony Sammut, Marufur Rahman, Claire M. Bridge, Jessica Hanson, Heather M. Judge, Bethany Lynch, Emily Maz, Hannah McMellon, Janet Middle, Georgia Williamson et al. · 2025 · Platelets
23. Clinical trials in long-term antiplatelet therapies
    Ridhima Goel, Usman Baber · 2019 · Current Opinion in Cardiology
24. Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta‐analysis
    Pradyumna Agasthi, Justin Z. Lee, Sai Harika Pujari, Andrew S. Tseng, Justin N. Shipman, Diana Almader‐Douglas, Hasan Ashraf, Farouk Mookadam, Floyd David Fortuin, Nirat Beohar et al. · 2020 · Journal of Arrhythmia
25. Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
    Surya Dharma · 2020 · International Journal of Angiology
26. Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy–An observational study
    Anna Holm, Martin Henriksson, Joakim Alfredsson, Magnus Janzon, Therese Johansson, Eva Swahn, Dominique Vial, Sofia Sederholm Lawesson · 2021 · PLoS ONE
27. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
    Kristina Gill, Nicholas Servati, Julie Flahive, Kyle Fraielli · 2021 · Journal of Cardiovascular Pharmacology and Therapeutics
28. Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model
    Sho Torii, Tadashi Yamamoto, Norihito Nakamura, Takeshi Ijichi, Ayako Yoshikawa, Yusuke Ito, Atsuhiro Sugidachi, Yuji Ikari, Gaku Nakazawa · 2021 · Circulation Reports
29. Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis
    Ghadeer K. Dawwas, Geoffrey D. Barnes, Eric A. Dietrich, Adam C. Cuker, Charles E. Leonard, Michael V. Genuardi, James D. Lewis · 2021 · American Heart Journal
30. Direct Oral Anticoagulants Compared with Vitamin K Antagonists for Left Ventricular Thrombus: A Systematic Review and Meta-analysis
    Shu Fang, Baozhen Zhu, Fan Yang, Zhe Wang, Qian Xiang, Yanjun Gong · 2022 · Current Pharmaceutical Design
31. Improved Reactive Oxygen Species Generation by Chiral Co 3 O 4 Supraparticles under Electromagnetic Fields
    Xiuxiu Wang, Maozhong Sun, Aihua Qu, Weiwei Wang, Meiru Lu, Xiao Lei Guo, Chen Chen, Changlong Hao, Liguang Xu, Chuanlai Xu et al. · 2021 · Angewandte Chemie
32. An antiplatelet response gene expression signature is associated with bleeding
    Kevin A. Friede, Rachel A. Myers, Jordan Gales, Ilya Y. Zhbannikov, Thomas L. Ortel, Svati Hasmukh Shah, William E. Kraus, Geoffrey S. Ginsburg, Deepak Voora · 2022 · Cardiovascular Research
33. Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
    Hideki Kitahara, Kazuya Tateishi, Yuki Shiko, Yusuke Inaba, Yoshio Kobayashi, Takahiro Inoue · 2022 · PLoS ONE
34. Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice
    Uwe Zeymer, Ralph Töelg, Harm Wienbergen, Hans‐Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf et al. · 2022 · The American Journal of Cardiology
35. Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article
    Ali Alshahrani, Sean S. O'Nunain · 2023 · The Egyptian Heart Journal
36. Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From Medicare
    Ainhoa Gómez-Lumbreras, Madeline Brendle, Krystal Moorman‐Bishir, Malinda Sunnita Tan, Daniel C. Malone · 2024 · Clinical Cardiology
37. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 2: Complications, post-revascularization care, and quality improvement
    Sara Jordan Hyland, Marion E Max, Rachael E Eaton, Stephanie A Wong, Susan Egbert, Danielle M. Blais · 2024 · American Journal of Health-System Pharmacy
38. Comprehensive analysis of Aspirin and Apixaban: thedevelopment, validation, and forced degradation studies of bulk drugs and in-house capsule formulations using the RP-HPLC method
    Tarang Patel · 2024 · American Journal of Translational Research
39. Antiplatelet, anticoagulant or both? A tool for pharmacists
    Alyssa Schmode, Margaret L. Ackman, Tammy J. Bungard · 2019 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
40. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting
    Jordan L. Lacoste, Cory L Hansen · 2019 · American Journal of Health-System Pharmacy
41. Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
    Е. И. Баранова, Zhanna Kobalava · 2019 · Russian Journal of Cardiology
42. Direct Oral Anticoagulants and Coronary Artery Disease: The Debacle of the Aspirin Era?
    Álvaro García‐Ropero, Ariana P. Vargas-Delgado, Carlos G. Santos‐Gallego, Juan J. Badimón · 2020 · Journal of Cardiovascular Pharmacology
43. Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
    Hyun‐Su Ha, Joongmin Kim, Young Soo Lee, Tae‐Hoon Kim, Jung‐Myung Lee, Jin‐Kyu Park, Jin‐Kyu Park, Ki‐Woon Kang, Jae‐Sun Uhm, Jae‐Sun Uhm et al. · 2020 · Yonsei Medical Journal
44. The year in cardiology: coronary interventions The year in cardiology 2019
    Andreas Baumbach, Christos V. Bourantas, Patrick W.J.C. Serruys, William C. Wijns · 2020 · Cardiologia Croatica
45. Incidence of aspirin resistance is higher in patients with acute coronary syndrome and atrial fibrillation than without atrial fibrillation
    Hasan Aydın Baş, Fatih Aksoy, Ali Bağcı, Ercan Varol, Ahmet Altınbaş · 2020 · Revista da Associação Médica Brasileira
46. Inhibition of Platelet Aggregation After Coronary Stenting in Patients Receiving Oral Anticoagulation
    Conrad Genz, Ruediger Christian Braun-Dullaeus · 2021 · Deutsches Ärzteblatt international
47. The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
    David S. Eccleston, Joseph M. Kim, Juriën M. ten Berg, Philippe Gabríel Steg, Deepak L. Bhatt, Stefan Hans Hohnloser, Anne de Veer, Matias Nordaby, Corinna Miede, Takeshi Kimura et al. · 2021 · Clinical Cardiology
48. Akutes Koronarsyndrom ohne persistierende ST-Streckenhebung – Was ist neu in den 2020-Leitlinien der ESC?
    Janine Pöss, Hölger Thiele · 2021 · Aktuelle Kardiologie
49. Antithrombotika und Antihämorrhagika
    Hans Wille · 2021 · Springer eBooks
50. Antithrombotic Treatment after Atrial Fibrillation Ablation
    Christos Konstantinos Antoniou, Panagiota Manolakou, Πέτρος Αρσένος, Polychronis Dilaveris, Konstantinos A. Gatzoulis, Dimitrios M. Tousoulis · 2020 · Current Pharmaceutical Design
51. Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
    Su‐Kiat Chua, Lung‐Ching Chen, Kou‐Gi Shyu, Jun-Jack Cheng, Huei-Fong Hung, Chiung-Zuan Chiu, Chiu-Mei Lin · 2020 · Journal of Clinical Medicine
52. Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis
    Felipe Fernando Mainka, Vinícius Lins Ferreira, Antonio M. Mendes, Gustavo Lenci Marques, Fernando Fernández-Llimós, Fernanda S. Tonin, Roberto Pontarolo · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
53. Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: A meta-analysis
    Abdelmoniem Moustafa, MohammadSaud Khan, Abdalla Marei, Mohd Amer Alsamman, Muhammad Baig, Marwan S Saad · 2020 · Avicenna Journal of Medicine
54. Clinical case of a paradoxical embolism that caused an acute myocardial infarction after deep vein thrombosis
    Yu. V. Larchikova, A. D. Ehrlikh, I SMETANINA, N. Yu. Zheltov · 2020 · Aterotromboz = Atherothrombosis
55. Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation
    Christopher Paul Cannon · 2021 · The American Journal of Cardiology
56. Real-World Experience With Antiplatelet Agents After Percutaneous Coronary Intervention in Patients With an Indication for an Oral Anticoagulant
    Richard Tanner, Michael Cronin, Lilly Macken, Ross T. Murphy, Andrew O Maree, Ihsan Ullah, John Cosgrave, Stephen A. O’Connor, Caroline Daly · 2021 · Journal of Cardiovascular Pharmacology
57. An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here?
    Jacopo Marazzato, Paolo Verdecchia, Michele Golino, Federico Blasi, Matteo Crippa, Roberto De Ponti, Fabio Angeli · 2021 · Expert Opinion on Pharmacotherapy
58. Changes in Antithrombotic Therapy Over Time and Durability of a Prasugrel WOEST-Like Regimen for Percutaneous Coronary Intervention Patients With Atrial Fibrillation ― Post Hoc Analysis of the PENDULUM Mono and PENDULUM Registries ―
    Kōichi Nakao, Kazushige Kadota, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Takashi Akasaka, Toshiro Shinke, Takafumi Ueno et al. · 2022 · Circulation Reports
59. Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital‐wide quality improvement initiative
    William Earle, George T. Abdallah, Sean Meagher, Kaden Shen, Charles Michael Gibson, Kalon K.L. Ho, Eric Alexander Secemsky · 2022 · Catheterization and Cardiovascular Interventions
60. Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation
    Julia Seeger, Jochen Wöhrle · 2020 · Core evidence
61. Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence
    Elisabetta Ricottini, Antonio Nenna, Rosetta Melfi, Sara Giannone, Mario Lusini, Germano Di Sciascio, Massimo Chello, Gian Paolo Ussia, Francesco Grigioni · 2020 · European Journal of Internal Medicine
62. From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach
    Giuseppe Boriani, Jacopo Francesco Imberti, Marco Vitolo · 2020 · European Journal of Internal Medicine
63. Antithrombotic Therapy for Stroke Patients with Cardiovascular Disease
    Aaron M. Gusdon, Salia Farrokh, James C. Grotta · 2021 · Seminars in Neurology
64. Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study
    Ashish D. Patel, Shaun G. Goodman, Mary Tan, Neville Suskin, Robert Samuel McKelvie, Andrew L. Mathew, Sohrab R. Lutchmedial, Payam Dehghani, Andrea Lavoie, Thao Thanh Huynh et al. · 2021 · Clinical Cardiology
65. Optimisation of oral anticoagulants for patients with atrial fibrillation within 12 months after percutaneous coronary intervention: A meta-analysis and systematic review
    Shuo Wang, Ying Liu, Linxin Wang, Haiqi Zuo, Yanfeng Tian, Yimeng Wang, Dechun Yin, Haiyu Zhang, Ye Tian · 2021 · IJC Heart & Vasculature
66. Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
    Si‐qi Lyu, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing‐hui Shao, Yanmin Yang · 2022 · Platelets
67. Tug of War Between Dual and Triple Antithrombotic Therapy in Atrial Fibrillation/PCI Patients With CKD
    Piera Capranzano, Dominick Joseph Angiolillo · 2019 · JACC: Cardiovascular Interventions
68. Complex antithrombotic combinations: how to find the perfect blend?
    Mark Roland Thomas, Erik Lerkevang Grove, Paulus F. Kirchhof · 2020 · Heart
69. Antithrombotic Strategies in Invasively Managed Patients with Non-ST Elevation Acute Coronary Syndromes and Non-Valvular Atrial Fibrillation in Romania
    Alexandru-George Cotoban, Cristian Alexandru Udroiu, Radu Vînă, Dragoş Vinereanu · 2021 · MAEDICA – a Journal of Clinical Medicine
70. Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement
    Kumbhani, Dharam J., Armbruster, Anastasia L., Cheng, Richard K., Chrispin, Jonathan, Fischer, Urs, Holbrook, Anne Marie, Joglar, Jose, Sevestre, Marie-Antoinette · 2026 · JACC
71. An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions
    Jian Zhou, Xuecheng Wang, Jinbo Yu, Yizhang Wu, Xiaorong Li, Xin Xie, XuMin Zhang, Dian Cheng, Bing Yang · 2023 · Clinical and Experimental Pharmacology and Physiology
72. Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
    Balen Abdulrahman, Richard J. Jabbour, Nick P. Curzen · 2023 · Interventional Cardiology Reviews Research Resources
73. Aspirin‐Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT‐3 Trial
    Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Andò, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka et al. · 2024 · Journal of the American Heart Association
74. Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention
    Mark Anthony Sammut, Robert F. Storey · 2024 · Expert Review of Cardiovascular Therapy
75. Hemorrhage risk associated with triple antithrombotic therapy: a focused real-world pharmacovigilance disproportional analysis study
    Kannan Sridharan, Gowri Sivaramakrishnan · 2025 · BMC Cardiovascular Disorders
76. Multimorbidity and Venous Thromboembolism: Epidemiological Evidence, Pathophysiology, Prophylactic and Therapeutic Anticoagulation Efficacy, Safety, and Difficulties. A Review
    Feng Liang, Wen Ren, Min Chao, Ruidong Cheng, Jingjing Ren · 2025 · Clinical and Applied Thrombosis/Hemostasis
77. Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes—Review of the Literature
    Michał Kosowski, Maciej Kocjan, Michalina Mazurkiewicz, Marta Gamrot-Wrzoł, Sabina Ryl, Krzysztof Nowakowski, Jakub Kawecki, Tomasz Kukulski, Damian Kawecki, Beata Morawiec · 2025 · Journal of Clinical Medicine
78. Argatroban plus dual antiplatelet therapy versus dual antiplatelet alone for acute atherothrombotic cerebral infarction
    Saki Nakashima, Satoshi Kodama, Shotaro Aso, Taisuke Jo, Hideo Yasunaga, Toshiaki Isogai, Hiroki Matsui, Yuichiro Shirota, Kiyohide Fushimi, Tatsushi Toda et al. · 2025 · International Journal of Stroke
79. Direct oral anticoagulant and antiplatelet therapy for extracranial neurovascular stenting in patients with atrial fibrillation
    Zheng Xu, Yigang Chen, Yun Jiang, Chuan Xu, Qingqing Gao, Feina Shi, Jinhua Zhang · 2025 · BMC Neurology
80. Gastrointestinal Hemorrhage in Patients Receiving Antithrombotic Therapy: Clinical Patterns and Prognosis from Two Tertiary Care Hospitals
    Hamdan S. AlGhamdi, Mohammed A Koshan, N.M. Alotaibi, Fahad Alotaibi, Faisal F. AlSubaie, Hussain Ali Ekhuraidah, Rayan Hasan Al Zahrani, Abed A. Al-Lehibi, Najd S. Al-Gazlan, Abdulrahman Abdullah Aljumah · 2025 · Saudi Journal of Medicine and Medical Sciences
81. Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Claudio Laudani, Luis Ortega‐Paz, Davide Capodanno, Dominick Joseph Angiolillo · 2025 · Expert Opinion on Drug Safety
82. Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers
    Erica Vetrano, Alfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, Giuseppina Tagliaferri, Alessia Piacevole, Mariarosaria Donnarumma, Ilaria Iadicicco, Sabrina Picco, Simona Maria Moretto et al. · 2025 · Pharmaceuticals
83. Anticoagulation Strategies for Left Ventricular Thrombus After Myocardial Infarction: A Review
    Adam Folman, Nicola Toukan, Ofer M. Kobo, Ariel Roguin, Maguli S Barel · 2025 · Journal of Clinical Medicine
84. Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndrome
    Christof Skos, Jovan Rogozarski, Marek A Postula, Ceren Eyileten, Cihan Ay, Bernd Jilma, Renate B. Schnabel, Jolanta Maria Siller-Matula · 2025 · Journal of Thrombosis and Haemostasis
85. Age-Stratified Mortality Impact of Atrial Fibrillation in Elderly NSTEMI Patients
    Ersin Doğanözü, Pınar Demir Gündoğmuş, Emrah Aksakal · 2026 · Journal of Cardiovascular Development and Disease
86. Are the Direct Oral Anticoagulants Better Than Warfarin for the Prevention and Treatment of Stroke and Atrial Fibrillation?
    Vittorio Pengo, Francesco Marongiu, Doris Barcellona · 2026 · Handbook of experimental pharmacology
87. Anticoagulant Effects of Albiflorin via Factor Xa Inhibition
    Xiao-Xuan Du, Yun Hee Jeong, Gyuri Han, Jong‐Sup Bae · 2026 · Journal of Medicinal Food
88. Cardiology: What You May Have Missed in 2025
    Marina Atalla, Vijay Gupta, Maham Khalid, William G. Kussmaul, Michael A. LaCombe · 2026 · Annals of Internal Medicine
89. Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry
    Andrea Rubboli, Graziella Pompei, S D R Salvatore De Rosa, Paolo Calabrò, Carolina Moretti, Bernardo Cortese, Mauro Colletta, Vanessa Porretta, Giuseppe Andò, Alessandro Sciahbasi · 2026 · Journal of Thrombosis and Thrombolysis
90. Cardiovascular Trials in Hemodialysis
    Arsalan Hamid, Paolo Raggi, Concetta Lipardi, Maria Borentain, Alar Irs, Patrick Rossignol, Sotirios Tsimikas, Iain C. Macdougall, Pierluigi Tricoci, Glenn Matthew Chertow et al. · 2026 · Journal of the American College of Cardiology
91. Antiplatelet Therapy And Percutaneous Coronary Interventions
    René Hameau D., Alberto Fuensalida, Jorge Quitral, Pablo Sepulveda Varela, Alejandro Martínez Sepúlveda, Ramón Corbalán Herreros, Sanjay Patel, Gonzalo Martı́nez-Rodrı́guez · 2020 · Current Cardiology Reviews
92. Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation
    Mei Qiu, Shu-Yan Liu, Hairong Zhou · 2021 · Medicine
93. Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention
    Qiang Wang, Keping Yang · 2021 · Medicine
94. Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study
    Chiao‐Chin Lee, Chiao‐Hsiang Chang, Yuan Hung, Chin‐Sheng Lin, Shih‐Ping Yang, Shu‐Meng Cheng, Fan-Han Yu, Wei‐Shiang Lin, Wen‐Yu Lin · 2021 · Thrombosis Journal
95. Differential Effects of Clopidogrel With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
    Ludwig Traby, Marietta Kollars, Alexandra Kaider, Jolanta Maria Siller-Matula, Oskar Steinbrecher, Michael Wolzt, Paul Alexander Kyrle, Sabine Eichinger · 2020 · Clinical Pharmacology & Therapeutics
96. Management des akuten Koronarsyndroms ohne ST-Strecken-Hebung
    María Rubini Giménez, Hölger Thiele, Janine Pöss · 2022 · Herz
97. Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients
    Eleni M. Gamvroulas, Aubrey E. Jones, John A. Saunders, Tara L. Jones, Daniel M. Witt · 2023 · BMC Cardiovascular Disorders
98. Predictive validation of existing bleeding and thromboembolic scores in elderly patients with comorbid atrial fibrillation and acute coronary syndrome
    Honghong Zhang, Qi LIU, Haijing Zhao, Yani Yu, Liuyang Tian, Yingyue Zhang, Zihao Fu, Zheng Li, Yue Zhu, Yuhan Ma et al. · 2023 · 老年心脏病学杂志：英文版
99. Atrial fibrillation and ischemic heart disease: (un)solved therapeutic dilemma?
    Valeria Gritti, Simona Pierini, Marco Ferlini, Silvia MAURI, Lucia Barbieri, Battistina Castiglioni, Corrado Lettieri, Luca Mircoli, Andrea Mortara, Daniele Nassiacos et al. · 2023 · Minerva Cardiology and Angiology
100. Comparative safety review of antithrombotic treatment options for patients with atrial fibrillation undergoing percutaneous coronary intervention
     Muhammed İbrahim Erbay, Nikolaos Pyrpyris, Shriraj Susarla, Sebahat Ulusan, Adriana Camila Mares, Tasha Phillips Wilson, Duo Lee, Aayushi Sood, Rahul Gupta · 2024 · Expert Opinion on Drug Safety